ESR1 and breast carcinoma: Tartrazine has also been classified as a xenoestrogen [44,45] that can bind to Estrogen Receptor α (ERα) in the Michigan Cancer Foundation-7 (MCF-7) cell line and induce a proliferative effect in breast cancer cells and increase the expression of an estrogen reporter gene [46].